Literature DB >> 7205249

The effect of intraperitoneal injection of GABA or GHBA on monoamine histofluorescence in the rat brain.

M Smiałowska, E Slusarska.   

Abstract

Using the Falck-Hillarp histofluorescence method we studied the effect of gamma-aminobutyric acid (GABA) or gamma-hydroxybutyric acid (GHBA) on catecholaminergic (CA) and serotoninergic (5-HT) neurons in the rat brain. Both GABA as well as GHBA enhanced the CA fluorescence in noradrenergic (NA) terminals in the cerebellar cortex, which suggested that the NA content increased in these terminals. GHBA but not GABA also enhanced the fluorescence in dopaminergic (DA) terminals in the neostriatum and limbic structures. No significant changes of fluorescence were found in 5-HT neurons after both compounds. The results obtained suggest that, apart from the known GABA-DA interaction, there exists also a GABA-NA interaction in the cerebellar cortex.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7205249     DOI: 10.1007/bf01254915

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  28 in total

1.  Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the alpha-antagonist piperoxane.

Authors:  J M Cedarbaum; G K Aghajanian
Journal:  Brain Res       Date:  1976-08-13       Impact factor: 3.252

2.  Baclofen and gamma-hydroxybutyrate: similar effects on cerebral dopamine neurones.

Authors:  M Da Prada; H H Keller
Journal:  Life Sci       Date:  1976-10-15       Impact factor: 5.037

3.  Selective accumulation of ( 3 H)GABA by stellate cells in rat cerebellar cortex in vivo.

Authors:  F Schon; L L Iversen
Journal:  Brain Res       Date:  1972-07-20       Impact factor: 3.252

4.  Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gammahydroxybutyric acid.

Authors:  N E Andén; T Magnusson; G Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow.

Authors:  G Stock; T Magnusson; N E Andén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway.

Authors:  J R Walters; R H Roth; G K Aghajanian
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

7.  Effect of gamma-aminobutyric acid on brain serotonin and catecholamines.

Authors:  N H Yessaian; A R Armenian; H C Buniatian
Journal:  J Neurochem       Date:  1969-10       Impact factor: 5.372

8.  Gamma-hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy.

Authors:  G K Aghajanian; R H Roth
Journal:  J Pharmacol Exp Ther       Date:  1970-10       Impact factor: 4.030

9.  Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep".

Authors:  R H Roth; Y Suhr
Journal:  Biochem Pharmacol       Date:  1970-12       Impact factor: 5.858

10.  The GABA-mimetic action of etomidate [proceedings].

Authors:  R H Evans; R G Hill
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.